Noun
tocilizumab (uncountable)
(pharmacology) A human monoclonal antibody against the interleukin-6 receptor. Used to attenuate counterproductive immune responses in certain diseases (autoimmune or infectious).
For example, in 4 months, Honduras went from a fatality rate of 14.5 percent to 2.66 percent because of its early treatment regimen, “Catracho”: colchicine, anti-inflammatories, tocilizumab, ivermectin, blood thinners, and hydroxychloroquine. Source: Internet
In Padua, the autoimmune medicine Tocilizumab has proven effective, but can only be used once it is established that no other viruses or bacteria are present in the patients’ bodies, he said. Source: Internet
Several drugs that target inflammatory cytokines are in clinical development for Covid-19, including anti-IL-6 monoclonal antibodies like Actemra (tocilizumab) and Regeneron Pharmaceuticals Kevzara (sarilumab). Source: Internet
Further support for interleukin-6 playing some sort of role comes from the of tocilizumab – a treatment that lessens the impact of interleukin-6 and reduces inflammation – to treat severe COVID-19. Source: Internet
Tocilizumab is approved to quieten the chatter of immune molecules in rheumatoid arthritis and in some types of cancer. Source: Internet
The arthritis drug Tocilizumab has shown early promise in preventing extreme inflammation in gravely ill Covid-19 patients, according to a French clinical study. Source: Internet